glp 1 source Science Behind GIP and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 Receptor Agonist Market Forecast
Description
Preservation of lean mass even in a moderate calorie deficit
doi: 10.1111/dom.14067
That's not who I am
It's also possible that you might do better on a different GLP-1 medication, like tirzepatide, instead
Real Results: In the most recent head-to-head study comparing tirzepatide to semaglutide, people taking tirzepatide lost an average of 20.2% of their body weight compared to 13.7% with semaglutide over 72 weeks
